NOAH welcomes Norbrook
NOAH has welcomed Norbrook Laboratories (GB) Ltd as its latest NOAH member. Voted in by the NOAH Board at its July meeting, Norbrook joins Cyton Biosciences and KRKA UK Ltd who have also recently joined the association.
Norbrook, based in Newry, Northern Ireland, is one of the largest, family owned, veterinary pharmaceutical companies in the world, with 5 manufacturing sites, including 3 in Newry.
NOAH chief executive Dawn Howard said: “We are delighted to welcome Norbrook to the association. We look forward to working together on the many issues and opportunities facing our sector at this time, not least on Brexit and in particular on how continuity of supply of animal medicines in both the UK and Ireland will be ensured after the UK leaves the EU, and how we can ensure that innovation in our sector continues to thrive here . We welcome our new members as it is important that we are able to say confidently that we effectively represent the UK animal health industry.”
Mark Collinson, General Manager of UK Commercial Operations at Norbrook, said: “Our decision to join NOAH is consistent with our strategy to become a world class provider of veterinary medicines and demonstrates our desire to help lead change and shape the best possible environment for our industry in the United Kingdom. We are confident our membership of NOAH will benefit our company, our industry, our customers and most importantly the animals we help to treat.”
Notes for Editors
For more information please contact Dawn Howard or Alison Glennon at NOAH on 020 8367 3131 or see www.noah.co.uk
NOAH represents the UK animal medicines industry. Its aim is to promote the benefits of safe, effective, quality medicines for the health and welfare of all animals.